MT
MetaVia Inc. (MTVA)
NASDAQ·Healthcare·Biotechnology
$1.59
+0.00%
Mkt Cap $3.17M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 26, 2026 | — | — | — | -$2.06 | $1.01 | +149.03% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$2.86 | -$1.54 | +46.15% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.32 | -$0.26 | +18.75% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.57 | -$0.36 | +36.84% | — | — |
| Q4 2024 Dec 31, 2024 | — | — | — | — | -$6.59 | — | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.73 | -$0.55 | +24.66% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$1.38 | -$1.85 | -34.06% | — | — |
| Q1 2024 Mar 31, 2024 | — | — | — | -$1.10 | -$14.51 | -1219.21% | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$11.51 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | -$0.88 | -$8.27 | -840.24% | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | -$1.04 | -$1.60 | -53.46% | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | -$0.48 | -$5.66 | -1079.58% | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$19.12 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$308.25 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$327.06 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$284.68 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$485.32 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$410.02 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$470.54 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$405.96 | — | — | — |